Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial

BACKGROUND: SGLT2 (sodium-glucose cotransporter-2) inhibitors improve heart failure–associated outcomes in patients with type 2 diabetes. In patients with heart failure, SGLT2 inhibitors will likely be coprescribed with a loop diuretic, but this combined effect is not well-defined. Our aim was to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Mordi, Natalie A., Mordi, Ify R., Singh, Jagdeep S., McCrimmon, Rory J., Struthers, Allan D., Lang, Chim C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594536/
https://www.ncbi.nlm.nih.gov/pubmed/32865004
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594536/
https://www.ncbi.nlm.nih.gov/pubmed/32865004
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048739

Ejemplares similares